NEW YORK — Lannett Co. and Amneal Pharmaceuticals LLC have launched the first generic versions of Abilify oral solution (aripiprazole 1 mg/ml), Otsuka Pharmaceutical’s antidepressant drug. Lannett said Tuesday that its Silarx Pharmaceuticals subsidiary received Food and Drug Administration for its generic version of Abilify oral solution. “Our generic aripiprazole 1 mg/ml oral solution product
PISCATAWAY, N.J. — Camber Pharmaceuticals has launched aripiprazole tablets, an antipsychotic medication, in a range of dosages. Camber said Thursday that the tablets come in strengths of 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg and are available in 30-count bottles. The product is a generic version of Abilify, from
WASHINGTON — The Food and Drug Administration has approved the first generic versions of Otsuka Pharmaceutical’s Abilify (aripiprazole), an antipsychotic drug. The FDA said Tuesday that Teva Pharmaceuticals, Alembic Pharmaceuticals, Hetero Labs and Torrent Pharmaceuticals have been cleared to market generic aripiprazole in multiple strengths and dosage forms. With the approval, Teva Pharmaceutical Industries Ltd. on Tuesday announced the U.S.
